Presentation and Management of IV Line Associated Thrombophlebitis

Clinical Presentation

The National Comprehensive Cancer Network recommends that IV line associated thrombophlebitis typically presents with pain, erythema, and tenderness along the course of the affected vein, often with a palpable tender cord, and requires prompt catheter removal, symptomatic treatment, and in some cases anticoagulation 1, 2
Pain, erythema, and tenderness involving the superficial vein in the extremity are the primary clinical symptoms of IV line associated thrombophlebitis, according to the Infectious Diseases Society of America 2, 3
A palpable tender cord along the course of the affected vein is often present, especially with peripherally inserted central catheter (PICC)-related superficial vein thrombosis (SVT), as noted by the National Comprehensive Cancer Network 1
Approximately 29% of hospitalized patients requiring intravenous therapy for more than 5 days develop PICC-related SVT, as reported by the National Comprehensive Cancer Network 1

Cancer patients, particularly those undergoing chemotherapy or with solid tumors, are at increased risk for developing thrombophlebitis, especially when S. aureus is involved, according to the Infectious Diseases Society of America 2
Male sex, active solid cancer, personal history of venous thromboembolism (VTE), and saphenofemoral involvement are significantly associated with concurrent or future deep vein thrombosis (DVT)/pulmonary embolism (PE) in patients with SVT, as noted by the National Comprehensive Cancer Network 1

Diagnosis is primarily based on clinical symptoms (pain, erythema, and tenderness), according to the National Comprehensive Cancer Network and the Infectious Diseases Society of America 1, 2
Comprehensive history and physical examination should be performed, as recommended by the National Comprehensive Cancer Network 1
Suppurative thrombophlebitis should be suspected in patients with persistent bacteremia or fungemia (positive blood cultures after 3 days of adequate antimicrobial therapy) without another source of intravascular infection, according to the Infectious Diseases Society of America 3

If a peripheral catheter is involved and no longer indicated, the first step is to remove the catheter, as recommended by the National Comprehensive Cancer Network 1
For PICC line-associated thrombophlebitis, catheter removal may not be necessary if the patient is treated with anticoagulation and/or symptoms resolve, according to the National Comprehensive Cancer Network 1
Prophylactic dose anticoagulation is recommended if there is symptomatic progression or progression on imaging, as noted by the National Comprehensive Cancer Network 1
Patients with suppurative thrombophlebitis due to catheter-related bloodstream infection should receive a minimum of 3-4 weeks of antimicrobial therapy, according to the Infectious Diseases Society of America 2

Approximately 10% of patients with symptomatic SVT develop thromboembolic complications (DVT, PE, extension or recurrence of SVT) at 3-month follow-up, as reported by the National Comprehensive Cancer Network 1
Septic pulmonary emboli and other metastatic infections may complicate suppurative thrombophlebitis, according to the Infectious Diseases Society of America 2